Urinary bladder smooth muscle (UBSM) exhibits spontaneous rhythmic contraction.
The triggering mechanisms by which UBSM exhibits spontaneous contraction still remain to be established. However, the spontaneous contraction of UBSM has been suggested to be intimately associated with action potentials generated in this smooth muscle cell. 1, 4, 5) Action potentials recorded in UBSM cells are also myogenic in nature, but disappear in the presence of L-type Ca 2ϩ channel inhibitors, showing Ca 2ϩ spike characteristics. Enhancement of Ca 2ϩ entry during a burst of action potentials could induce a phasic contraction in this smooth muscle. 1, 5) Functional expression of voltage-gated L-type Ca 2ϩ channels in UBSM cells 6, 7) supports this assumption. A significant role of Ca 2ϩ spike action potential in inducing UBSM spontaneous contraction is also endorsed by the findings that this mechanical activity is sensitive to L-type Ca 2ϩ channel inhibitors. [1] [2] [3] However, our previous findings show that most of the components of UBSM mechanical activity can be generated in the presence of nisoldipine or diltiazem, although these Ca 2ϩ channel inhibitors completely eliminate the generation of action potential. 3, 8) This result implies that the action potential is not the exclusive triggering mechanism by which spontaneous contraction is induced in UBSM. 8) The possible existence of a pacemaker mechanism other than the action potential can also be supported by an apparent dissociation between membrane electrical events and mechanical activity in the presence of 2-aminoethoxydiphenyl borate (2-APB).
9) The inositol 1,4,5-trisphosphate (IP 3 ) receptor-inhibitory property of this compound 10, 11) leads to the assumption that the activation of phospholipase C (PLC) and subsequent IP 3 -induced Ca 2ϩ release system plays a role in inducing spontaneous mechanical activity of UBSM.
The present study was thus carried out to determine whether activation of PLC is involved in the generation of UBSM spontaneous contraction. Our present findings to show substantial diminishment of UBSM rhythmic contraction by two different PLC inhibitors support a role for the IP 3 -induced Ca 2ϩ release mechanism as an alternative trigger to induce spontaneous mechanical activity of this smooth muscle.
MATERIALS AND METHODS
Male and female guinea pigs (300-450 g) were housed under controlled conditions (temperature 21-22°C, relative air humidity 50Ϯ5%). Food and water were available ad libitum to all animals. This study was conducted in accordance with the Guidelines for the Care and Use of Laboratory Animals of Toho University School of Pharmaceutical Sciences, accredited by the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.
Preparation of UBSM The guinea pigs were sacrificed by a blow to the head and the urinary bladders were immediately removed and placed in ice-cold nominally Ca release mechanism as an alternative triggering system for inducing spontaneous mechanical activity of UBSM. The present results support the idea that the action potential is not the sole pacemaker mechanism by which spontaneous contraction is induced in UBSM.
Key words urinary bladder smooth muscle; spontaneous contraction; phospholipase C; IP 3 -induced Ca 2ϩ release; U-73122; 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate rinsing the urinary bladder with the dissection solution, the tissue was pinned to the bottom of a silicone-coated Petri plate containing the dissection solution. The UBSM strip (detrusor muscle, 1-2 mm in widthϫ10 mm in length) for mechanical study was prepared as reported previously. 3, 12) For intracellular recordings, a thin layer of muscle bundles (three to five bundles) was prepared (1-3 mm in widthϫ3-6 mm in length). 8, 9) Measurement of Spontaneous Rhythmic Contraction of UBSM Spontaneous rhythmic contractions were recorded as reported previously. 3, 8) Tension changes were isometrically recorded with a force-displacement transducer (TB-612T, Nihon-Kohden, Tokyo, Japan) connected to a minipolygraph (Signal Conditioner: Model MSC-2, Labo Support, Co., Ltd., Osaka, Japan). Data were collected with MacLab/400 TM and Chart TM (Version 3.5.6) software (ADInstruments Japan, Tokyo, Japan). UBSM spontaneous contractile activity was expressed as averaged contraction amplitude and its frequency for a period of 5 min as in the previous study 3) ; they were expressed as relative to control values (in the absence of pharmacological intervention) for evaluating PLC inhibitors on the contractile activity of UBSM.
Intracellular Recording of Membrane Potential of UBSM Cells The thin strip of UBSM was pinned to the silicon rubber bottom of a water-jacketed recording chamber (15 ml) filled with Krebs-Henseleit solution (mM: NaCl, 122; KCl, 4.7; NaHCO 3 , 15.5; NaH 2 PO 4 , 1.2; CaCl 2 , 2.5; MgCl 2 , 1.2; glucose, 11.8, 37Ϯ0.5°C) gassed with 95% O 2 -5% CO 2 (pHϭ7.4). To facilitate intracellular recordings, tissue movement was reduced by increasing the osmolality with the addition of 120 g sucrose per liter of solution. 5) A microelectrode was pulled on a Flaming/Brown micropipetter puller (Model P-97/IVF, Sutter Instruments, Novato, CA, U.S.A.) and had high resistance of 70-90 MW when filled with 1 M KCl. The transmembrane potential was measured with microelectrode preamplifier with high input impedance and capacity neutralization (model MEZ-7101, Nihon-Kohden). Data were collected with MacLab/400 TM and Chart TM (Version 3.5.6) software (ADInstruments Japan). The membrane potential was measured as the difference between the reference electrode in the bath and the intracellular microelectrode. The action potential parameter that was mainly analyzed was change in frequency.
Drugs Tetrodotoxin (TTX) citrate (Sigma-RBI, St. Louis, MO, U.S.A.); atropine (Tokyo Kasei, Tokyo, Japan); phentolamine mesylate (Ciba-Geigy, Takarazuka, Japan); propranolol (Zeneca, Osaka, Japan); suramin, 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), U-73122 and U-73343 (Sigma). All other chemicals used in the present study were commercially available and of reagent grade. U-73122, U-73343 and NCDC were dissolved in 100% ethanol to give stock solutions of 10 mM. All other drugs were prepared as aqueous solutions and diluted with distilled water. Final ethanol concentrations in the bath medium did not exceed 1%. All drugs are expressed in molar concentrations in the bathing solution.
Statistical Analysis The data are presented as mean valuesϮS.E.M. and n refers to the number of experiments. The significance of the difference between mean values was evaluated using the paired Student's t-test. A p value less than 0.05 was considered statistically significant. Figure 1 shows the effects of U-73122 on the spontaneous rhythmic contraction of guinea pig UBSM. In the presence of U-73122 (10 mM), the amplitude of spontaneous contraction was significantly suppressed (Figs. 1A, B, left panel) . The occurrence of mechanical activity, which was expressed as changes in its frequency, was also diminished by 10 mM U-73122, although the difference was not statistically significant (Fig. 1B, right panel) . In contrast, an inactive form of U-73122, U-73343 (10 mM), did not affect either contraction amplitude or its frequency (Fig. 1C) . U-73122 (10 mM) did not diminish the occurrence of the action potential: the action potential frequency was 0.08 Hz in the absence of U-73122 and it was 0.16 Hz in its presence (nϭ2 for each). Resting membrane potential and action potential amplitude in the absence of U-73122 were Ϫ52.8 mV and 32.7 mV, and they were Ϫ43.9 mV and 33.5 mV in its presence (nϭ2 for each).
RESULTS
A substantial diminishment of UBSM spontaneous contraction was also obtained with another putative PLC inhibitor, NCDC (Fig. 2) . In the presence of NCDC (50 mM), amplitude of the spontaneous contraction was strongly attenuated ( Fig. 2A, B , left panel), although its frequency was increased with this concentration of NCDC (Fig. 2B, tion potential amplitude were slightly altered by NCDC (50 mM): resting membrane potential and the amplitude of action potential in the absence of NCDC were Ϫ46.3Ϯ4.3 mV and 39.0Ϯ2.8 mV, and they were Ϫ42.6Ϯ4.7 mV and 30.7Ϯ 2.9 mV in its presence (nϭ5, pϽ0.05 for both).
DISCUSSION
In a previous study, we showed that 2-APB strongly diminishes spontaneous mechanical activity of guinea pig UBSM. 9) In the present study, the spontaneous contraction of guinea pig UBSM was also suppressed significantly by U-73122 and NCDC. Diminishment of UBSM contraction by the IP 3 receptor antagonist (2-APB) and PLC inhibitors (U-73122 and NCDC) strongly suggests a role for the activation of PLC and subsequent IP 3 -induced Ca 2ϩ release mechanism in the spontaneous mechanical activity of this smooth muscle.
U-73122 attenuated UBSM spontaneous contraction at a concentration of 10 mM (Fig. 1) . The reduction in the mechanical activity in the presence of 10 mM U-73122 can be ascribed to the inhibited PLC activity by this compound because of the following reasons: 1) This concentration (10 mM) of U-73122 has been shown to inhibit strongly the production of IP 3 in rat pancreatic acinar cells stimulated with cholecystokinin or carbachol (by 80% to 90%) without affecting cAMP formation in response to secretin. 13) 2) U-73122 (10 mM) almost abolishes the [Ca 2ϩ ] i signaling generated in responses to cholecystokinin and/or carbachol in acinar cells 13) and to phenylephrine in dog pulmonary artery smooth muscle cells. 14) 3) The inability of U-73343, an inactive form of U-73122, to attenuate UBSM contraction (Fig.  1C) provides further evidence that suppression of PLC activity is involved in the reduction of UBSM mechanical activity by U-73122. On the other hand, the usefulness of NCDC as a PLC inhibitor in smooth muscle mechanical studies is strongly supported by the finding that this compound (60 mM) inhibits 5-hydroxytryptamine-activated phosphoinositide hydrolysis without affecting high-potassium (50 mM)-induced contraction in the rat aorta. 15) NCDC (100 mM) also inhibits the production of IP 3 in pig coronary artery stimulated with acetylcholine and mechanical stretch. 16) In general, PLC activity is enhanced with the stimulation of chemical receptors. However, the enzyme activity can be also increased without any chemical receptor stimulations. For instance, in heart muscle 17) and vascular smooth muscle, 16) mechanical stimulation such as stretch enhances the production of IP 3 . This implies that muscle stretch itself directly or indirectly accelerates PLC activity to enhance IP 3 production. UBSM possesses a mechanosensor mechanism(s) for muscle stretch, 4, 18) and it is plausible that IP 3 production is exaggerated due to muscle stretch in UBSM.
Although UBSM mechanical activity is partly influenced through alterations in the action potential, the changes in smooth muscle cell membrane excitability are not the preclusive trigger mechanism for the spontaneous rhythmic contraction in this smooth muscle. 8, 9) Our present findings indicate the possibility that the alteration in PLC activity also functions as a triggering mechanism to evoke spontaneous muscle contraction in this type of muscle tissue. Vol. 26, No. 8
Fig. 2. NCDC Inhibits Spontaneous Contraction of Guinea Pig UBSM
A: A representative trace illustrating the effects of NCDC (50 mM) on mechanical activity. The UBSM tension changes were recorded in the presence of the blocker cocktail described in the legend to Fig. 1 . B: Summary data showing the effects of NCDC on the amplitude and frequency of spontaneous rhythmic contraction of UBSM. Data are expressed as meanϮS.E.M. of four experiments. * * pϽ0.01 shows the significant differences between two groups.
